Back to search
FDAFDA · Food and drugs·Recall number Z-2535-2024

NavaClick Syringe and Needle, Model Number LIN02

Published August 14, 2024 · Recall initiated: July 12, 2024

Summary

FDA records medical device Class III recall Z-2535-2024, published August 14, 2024 and initiated July 12, 2024. Recalling firm: LINEAGE BIOMEDICAL, INC; Status: Ongoing; Reported quantity: 215 cartons (containing 50 pouches each); Lot: Product Level Labeling Full UDI: (01)00860009080522(17)250416(10)24107. Packaging Carton Level Labeling Full UDI: (01)208600090805(17)250416(10)24107. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect GTIN number on carton.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
LINEAGE BIOMEDICAL, INC
Distributor
US Nationwide distribution in the states of Michigan and South Carolina.
Lot
Product Level Labeling Full UDI: (01)00860009080522(17)250416(10)24107. Packaging Carton Level Labeling Full UDI: (01)208600090805(17)250416(10)24107
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NavaClick Syringe and Needle, Model Number LIN02 recalled?

Yes. FDA published recall Z-2535-2024 on August 14, 2024. Reported hazard: Incorrect GTIN number on carton.

What should I do if I have this product?

Voluntary: Firm initiated · Letter